Brightman B K, Farmer C, Fan H
Department of Molecular Biology and Biochemistry, University of California, Irvine 92717.
J Virol. 1993 Dec;67(12):7140-8. doi: 10.1128/JVI.67.12.7140-7148.1993.
Mo+PyF101 M-MuLV is a variant Moloney murine leukemia virus containing polyomavirus F101 enhancers inserted just downstream from the M-MuLV enhancers in the long terminal repeat (LTR). The protein coding sequences for this virus are identical to those of M-MuLV. Mo+PyF101 M-MuLV induces T-cell disease with a much lower incidence and longer latency than wild-type M-MuLV. We have previously shown that Mo+PyF101 M-MuLV is defective in preleukemic events induced by wild-type M-MuLV, including splenic hematopoietic hyperplasia, bone marrow depletion, and generation of recombinant mink cell focus-inducing viruses (MCFs). We also showed that an M-MCF virus driven by the Mo+PyF101 LTR is infectious in vitro but does not propagate in mice. However, in these experiments, when a pseudotypic mixture of Mo+PyF101 M-MuLV and Mo+PyF101 MCF was inoculated into newborn NIH Swiss mice, they died of T-cell leukemia at times almost equivalent to those induced by wild-type M-MuLV. Tumor DNAs from Mo+PyF101 M-MuLV-Mo+PyF101 MCF-inoculated mice were examined by Southern blot analysis. The predominant forms of Mo+PyF101 MCF proviruses in these tumors contained added sequences in the U3 region of the LTR. The U3 regions of representative tumor-derived variant Mo+PyF101 MCFs were cloned by polymerase chain reaction amplification, and sequencing indicated that they had acquired an additional copy of the M-MuLV 75-bp tandem repeat in the enhancer region. NIH 3T3 cell lines infected with altered viruses were obtained from representative Mo+PyF101 M-MuLV-Mo+PyF101 MCF-induced tumors, and mice were inoculated with the recovered viruses. Leukemogenicity was approximately equivalent to that in the original Mo+PyF101 M-MuLV-Mo+PyF101 MCF viral stock. Southern blot analysis on the resulting tumors now predominantly revealed loss of the polyomavirus sequences. These results suggest that the suppressive effects of the PyF101 sequences on M-MuLV-induced disease and potentially on MCF propagation were overcome in two ways: by triplication of the M-MuLV direct repeats and by loss of the polyomavirus sequences.
Mo+PyF101 M-MuLV是一种莫洛尼氏鼠白血病病毒变异体,其多瘤病毒F101增强子插入到长末端重复序列(LTR)中M-MuLV增强子下游紧邻的位置。该病毒的蛋白质编码序列与M-MuLV相同。与野生型M-MuLV相比,Mo+PyF101 M-MuLV诱发T细胞疾病的发生率更低,潜伏期更长。我们之前已经表明,Mo+PyF101 M-MuLV在野生型M-MuLV诱导的白血病前期事件中存在缺陷,包括脾脏造血组织增生、骨髓耗竭以及重组水貂细胞灶形成病毒(MCF)的产生。我们还表明,由Mo+PyF101 LTR驱动的M-MCF病毒在体外具有感染性,但在小鼠体内不会传播。然而,在这些实验中,当将Mo+PyF101 M-MuLV和Mo+PyF101 MCF的假型混合物接种到新生的NIH瑞士小鼠体内时,它们死于T细胞白血病的时间几乎与野生型M-MuLV诱导的时间相同。通过Southern印迹分析检测了接种Mo+PyF101 M-MuLV-Mo+PyF101 MCF的小鼠的肿瘤DNA。这些肿瘤中Mo+PyF101 MCF前病毒的主要形式在LTR的U3区域含有额外的序列。通过聚合酶链反应扩增克隆了代表性肿瘤衍生的变异Mo+PyF101 MCF的U3区域,测序表明它们在增强子区域获得了M-MuLV 75 bp串联重复序列的额外拷贝。从代表性的Mo+PyF101 M-MuLV-Mo+PyF101 MCF诱导的肿瘤中获得了感染改变病毒的NIH 3T3细胞系,并将回收的病毒接种到小鼠体内。致白血病性与原始的Mo+PyF101 M-MuLV-Mo+PyF101 MCF病毒原液大致相当。对产生的肿瘤进行Southern印迹分析,现在主要显示多瘤病毒序列缺失。这些结果表明,PyF101序列对M-MuLV诱导的疾病以及可能对MCF传播的抑制作用通过两种方式被克服:通过M-MuLV直接重复序列的三倍化以及多瘤病毒序列的缺失。